These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 26376649)

  • 1. Treatment against human endogenous retrovirus: a possible personalized medicine approach for multiple sclerosis.
    Curtin F; Perron H; Faucard R; Porchet H; Lang AB
    Mol Diagn Ther; 2015 Oct; 19(5):255-65. PubMed ID: 26376649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical and early clinical development of GNbAC1, a humanized IgG4 monoclonal antibody targeting endogenous retroviral MSRV-Env protein.
    Curtin F; Perron H; Kromminga A; Porchet H; Lang AB
    MAbs; 2015; 7(1):265-75. PubMed ID: 25427053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase IIa randomised clinical study of GNbAC1, a humanised monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus in multiple sclerosis patients.
    Derfuss T; Curtin F; Guebelin C; Bridel C; Rasenack M; Matthey A; Du Pasquier R; Schluep M; Desmeules J; Lang AB; Perron H; Faucard R; Porchet H; Hartung HP; Kappos L; Lalive PH
    Mult Scler; 2015 Jun; 21(7):885-93. PubMed ID: 25392325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MSRV envelope protein is a potent, endogenous and pathogenic agonist of human toll-like receptor 4: Relevance of GNbAC1 in multiple sclerosis treatment.
    Madeira A; Burgelin I; Perron H; Curtin F; Lang AB; Faucard R
    J Neuroimmunol; 2016 Feb; 291():29-38. PubMed ID: 26857492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Endogenous Retrovirus and Neuroinflammation in Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
    Faucard R; Madeira A; Gehin N; Authier FJ; Panaite PA; Lesage C; Burgelin I; Bertel M; Bernard C; Curtin F; Lang AB; Steck AJ; Perron H; Kuntzer T; Créange A
    EBioMedicine; 2016 Apr; 6():190-198. PubMed ID: 27211560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GNbAC1, a humanized monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus: a first-in-humans randomized clinical study.
    Curtin F; Lang AB; Perron H; Laumonier M; Vidal V; Porchet HC; Hartung HP
    Clin Ther; 2012 Dec; 34(12):2268-78. PubMed ID: 23200102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do Antiretroviral Drugs Protect From Multiple Sclerosis by Inhibiting Expression of MS-Associated Retrovirus?
    Morandi E; Tanasescu R; Tarlinton RE; Constantin-Teodosiu D; Gran B
    Front Immunol; 2018; 9():3092. PubMed ID: 30740110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of transcribed human endogenous retrovirus W env loci clarifies the origin of multiple sclerosis-associated retrovirus env sequences.
    Laufer G; Mayer J; Mueller BF; Mueller-Lantzsch N; Ruprecht K
    Retrovirology; 2009 Apr; 6():37. PubMed ID: 19368703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase IIa randomized clinical study testing GNbAC1, a humanized monoclonal antibody against the envelope protein of multiple sclerosis associated endogenous retrovirus in multiple sclerosis patients - a twelve month follow-up.
    Derfuss T; Curtin F; Guebelin C; Bridel C; Rasenack M; Matthey A; Du Pasquier R; Schluep M; Desmeules J; Lang AB; Perron H; Faucard R; Porchet H; Hartung HP; Kappos L; Lalive PH
    J Neuroimmunol; 2015 Aug; 285():68-70. PubMed ID: 26198921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new therapeutic approach for type 1 diabetes: Rationale for GNbAC1, an anti-HERV-W-Env monoclonal antibody.
    Curtin F; Bernard C; Levet S; Perron H; Porchet H; Médina J; Malpass S; Lloyd D; Simpson R;
    Diabetes Obes Metab; 2018 Sep; 20(9):2075-2084. PubMed ID: 29749030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brains and peripheral blood mononuclear cells of multiple sclerosis (MS) patients hyperexpress MS-associated retrovirus/HERV-W endogenous retrovirus, but not Human herpesvirus 6.
    Mameli G; Astone V; Arru G; Marconi S; Lovato L; Serra C; Sotgiu S; Bonetti B; Dolei A
    J Gen Virol; 2007 Jan; 88(Pt 1):264-274. PubMed ID: 17170460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human endogenous retrovirus W in brain lesions: Rationale for targeted therapy in multiple sclerosis.
    van Horssen J; van der Pol S; Nijland P; Amor S; Perron H
    Mult Scler Relat Disord; 2016 Jul; 8():11-8. PubMed ID: 27456869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of Proinflammatory Multiple Sclerosis-Associated Retrovirus Envelope Protein by Human Herpesvirus-6A and CD46 Receptor Engagement.
    Charvet B; Reynaud JM; Gourru-Lesimple G; Perron H; Marche PN; Horvat B
    Front Immunol; 2018; 9():2803. PubMed ID: 30574140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and activation by Epstein Barr virus of human endogenous retroviruses-W in blood cells and astrocytes: inference for multiple sclerosis.
    Mameli G; Poddighe L; Mei A; Uleri E; Sotgiu S; Serra C; Manetti R; Dolei A
    PLoS One; 2012; 7(9):e44991. PubMed ID: 23028727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The aliens inside human DNA: HERV-W/MSRV/syncytin-1 endogenous retroviruses and neurodegeneration.
    Dolei A; Uleri E; Ibba G; Caocci M; Piu C; Serra C
    J Infect Dev Ctries; 2015 Jul; 9(6):577-87. PubMed ID: 26142666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of immune responses against multiple sclerosis-associated retrovirus/human endogenous retrovirus W in patients with multiple sclerosis.
    Ruprecht K; Gronen F; Sauter M; Best B; Rieckmann P; Mueller-Lantzsch N
    J Neurovirol; 2008 Apr; 14(2):143-51. PubMed ID: 18444086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel reliable real-time PCR for differential detection of MSRVenv and syncytin-1 in RNA and DNA from patients with multiple sclerosis.
    Mameli G; Poddighe L; Astone V; Delogu G; Arru G; Sotgiu S; Serra C; Dolei A
    J Virol Methods; 2009 Oct; 161(1):98-106. PubMed ID: 19505508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natalizumab inhibits the expression of human endogenous retroviruses of the W family in multiple sclerosis patients: a longitudinal cohort study.
    Arru G; Leoni S; Pugliatti M; Mei A; Serra C; Delogu LG; Manetti R; Dolei A; Sotgiu S; Mameli G
    Mult Scler; 2014 Feb; 20(2):174-82. PubMed ID: 23877972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human endogenous retroviruses and multiple sclerosis: Causation, association, or after-effect?
    Morandi E; Tarlinton RE; Tanasescu R; Gran B
    Mult Scler; 2017 Jul; 23(8):1050-1055. PubMed ID: 28406354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The aliens inside us: HERV-W endogenous retroviruses and multiple sclerosis.
    Dolei A
    Mult Scler; 2018 Jan; 24(1):42-47. PubMed ID: 29307292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.